SculpSure is now FDA-cleared for non-invasive lipolysis of submental fat, which uses light-based technology to safely heat and destroy fat under the skin. This treatment complements the platform’s other indications including the abdomen, flanks, back and inner and outer thighs. This new technology is optimised to eliminate unwanted fat under the chin. Our applicator design is perfect for providing precise and effective treatments resulting in a slimmer appearance of the chin and neck.
Don’t turn patients away—unlike other products indicated for individuals with a BMI ≤30, SculpSure’s submental application can treat individuals with a BMI of up to 43. Our technology gives you the ability to treat more patients, resulting in more revenue for your practice.
1. American Society for Dermatologic Surgery (ASDS) 2017 Consumer Survey on Cosmetic Dermatologic Procedures.
2. Overweight & Obesity Statistics. National Institute of Diabetes and Digestive and Kidney Diseases. 2010. https://www.niddk.nih.gov/health-information/health-statistics/overweight-obesity.
3. Cynosure clinical data on file, Cynosure, Inc.
Models used for illustrative purposes only. Individual results may vary and are not guaranteed. SculpSure is intended for non-invasive fat reduction of the submental (chin) area, abdomen, flanks, back, inner and outer thighs. SculpSure submental is not a weight loss solution.
Practitioners were compensated for their product endorsements.
© 2017. Hologic, Inc. Cynosure and SculpSure are registered trademarks of Hologic, Inc. A Smarter Way to Sculpt is a trademark of Hologic, Inc. Hologic, Inc. owns exclusive rights to photography. Use of photography without written permission of Hologic is prohibited.